← Browse by Condition
Medical Condition

cytokine release syndrome

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05905328 Phase 1, Phase 2
Recruiting

Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy

Enrollment
54 pts
Location
United States
Sponsor
CytoAgents, Inc.
View Trial →